1. The Role of Thromboelastography in a Patient on Defibrotide Therapy with Abnormal Coagulation Studies 
Joanna Lynn Wigfield, D.O., Dana Salzberg, MD, Niketa C. Shah, MD, Holly Miller, MD, Kyrie Magee, CPNP, MSN, RN, Kristen Beebe, MS, PA-C, Roberta H. Adams, MD, Leon Su, M.D. 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 3, Pages S295-S296 (March 2016)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
TEG during defibrotide therapy with corresponding abnormal RCT. A) At initial diagnosis of SOS B) Post transfusion with TEG normalization prior to defibrotide therapy C) Coagulopathy that developed day +13 demonstrated by abnormal TEG and RCT D) Corrected TEG but persistent abnormal RCT following plasma transfusion
Biology of Blood and Marrow Transplantation  , S295-S296DOI: ( /j.bbmt )
Copyright © Terms and Conditions